Hansa Biopharma AB (OSTO:HNSA) Days Sales Outstanding : 121.32 (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Hansa Biopharma AB Days Sales Outstanding?

Hansa Biopharma AB's average Accounts Receivable for the three months ended in Mar. 2024 was kr74.4 Mil. Hansa Biopharma AB's Revenue for the three months ended in Mar. 2024 was kr56.0 Mil. Hence, Hansa Biopharma AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 121.32.

The historical rank and industry rank for Hansa Biopharma AB's Days Sales Outstanding or its related term are showing as below:

OSTO:HNSA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 13.31 Med: 30.81 Max: 146.17
Current: 146.17

During the past 13 years, Hansa Biopharma AB's highest Days Sales Outstanding was 146.17. The lowest was 13.31. And the median was 30.81.

OSTO:HNSA's Days Sales Outstanding is ranked worse than
77.87% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs OSTO:HNSA: 146.17

Hansa Biopharma AB's Days Sales Outstanding increased from Mar. 2023 (104.81) to Mar. 2024 (121.32).

Hansa Biopharma AB Days Sales Outstanding Historical Data

The historical data trend for Hansa Biopharma AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansa Biopharma AB Days Sales Outstanding Chart

Hansa Biopharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

31.47

18.91

52.91

21.34

115.17

Hansa Biopharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															104.81	146.61	271.83	128.31	121.32

Competitive Comparison of Hansa Biopharma AB's Days Sales Outstanding

For the Biotechnology subindustry, Hansa Biopharma AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hansa Biopharma AB's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hansa Biopharma AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Hansa Biopharma AB's Days Sales Outstanding falls into.

Hansa Biopharma AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Hansa Biopharma AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (8.36	+	76.266)	/	2 )	/	134.094	*	365
=	42.313					/	134.094	*	365
=	115.17

Hansa Biopharma AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (76.266	+	72.596)	/	2 )	/	55.981	*	365 / 4
=	74.431					/	55.981	*	365 / 4
=	121.32

Hansa Biopharma AB (OSTO:HNSA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Hansa Biopharma AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Hansa Biopharma AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansa Biopharma AB (OSTO:HNSA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hansa Biopharma AB (OSTO:HNSA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

HNSBF:USA 0RC7:UK 24H:Germany

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.hansabiopharma.com

Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Hansa Biopharma AB (OSTO:HNSA) Headlines

No Headlines